American Journal of Bioethics 20 (9):4-17 (2020)
| Authors |
|
| Abstract |
Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research....
|
| Keywords | No keywords specified (fix it) |
| Categories | (categorize this paper) |
| ISBN(s) | |
| DOI | 10.1080/15265161.2020.1795529 |
| Options |
Mark as duplicate
Export citation
Request removal from index
|
Download options
References found in this work BETA
How Payment For Research Participation Can Be Coercive.Joseph Millum & Michael Garnett - 2019 - American Journal of Bioethics 19 (9):21-31.
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.Ezekiel J. Emanuel, Govind Persad, Ross Upshur, Beatriz Thome, Michael Parker, Aaron Glickman, Cathy Zhang, Connor Boyle & James P. Phillips - 2020 - New England Journal of Medicine:10.1056/NEJMsb2005114.
The Toughest Triage — Allocating Ventilators in a Pandemic.Robert D. Truog, Christine Mitchell & George Q. Daley - 2020 - New England Journal of Medicine.
View all 10 references / Add more references
Citations of this work BETA
Adopting an Anti-Racist Model of COVID-19 Drug Allocation and Prioritization.Akilah A. Jefferson - 2020 - American Journal of Bioethics 20 (9):33-36.
The Case for Methodological Pluralism in Medical Science.Sarah J. L. Edwards, Thomas Bock, Ulo Palm, Sally Wang, Glen Cheng, Lixia Wang & Peter Pitts - 2020 - American Journal of Bioethics 20 (9):39-41.
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.Eli Weber & Mark J. Bliton - 2020 - American Journal of Bioethics 20 (9):31-33.
The Inherent Unfairness of COVID-19 Drug Access Pathways.Kayte Spector-Bagdady, Misty Gravelin, Kevin J. Weatherwax & Andrew G. Shuman - 2020 - American Journal of Bioethics 20 (9):18-20.
Fairness and Protection for the Vulnerable: Lessons From Esketamine.Gin S. Malhi & Julian Savulescu - 2020 - American Journal of Bioethics 20 (9):36-38.
View all 11 citations / Add more citations
Similar books and articles
No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.Jaime Webb, Lesha Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):W1-W4.
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically.Lawrence O. Gostin, Eric A. Friedman & Sarah A. Wetter - 2020 - Hastings Center Report 50 (2):8-12.
Who Should Go First in Trials with Scarce Agents? The Views of Potential Participants.Rebecca D. Pentz, Anne L. Flamm, Jeremy Sugarman, Marlene Z. Cohen, Zhiheng Xu, Roy S. Herbst & James L. Abbruzzese - 2007 - IRB: Ethics & Human Research 29 (4):1.
Facilitating Both Evidence and Access: Improving FDA's Accelerated Approval and Expanded Access Pathways.Holly Fernandez Lynch & Alison Bateman-House - 2020 - Journal of Law, Medicine and Ethics 48 (2):365-372.
Delaying Approval of a Critical Drug: Safety, Efficacy, Economics, Compassion. [REVIEW]Leo T. Rosenberg - 1994 - Journal of Medical Humanities 15 (4):243-250.
An analysis of common ethical justifications for compassionate use programs for experimental drugs.Kasper Raus - 2016 - BMC Medical Ethics 17 (1):60.
Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps.Hiroyasu Ino, Eisuke Nakazawa & Akira Akabayashi - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (1):51-58.
COVID-19 and Health-Related Authority Allocation Puzzles.Michael da Silva - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (1):25-36.
Medical Research in Clinical Emergency Settings in Europe.S. Lotjonen - 2002 - Journal of Medical Ethics 28 (3):183-187.
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.Ezekiel J. Emanuel, Govind Persad, Ross Upshur, Beatriz Thome, Michael Parker, Aaron Glickman, Cathy Zhang, Connor Boyle & James P. Phillips - 2020 - New England Journal of Medicine:10.1056/NEJMsb2005114.
Scarcity in the Covid‐19 Pandemic.Mildred Z. Solomon, Matthew Wynia & Lawrence O. Gostin - 2020 - Hastings Center Report 50 (2):3-3.
Age Matters but It Should Not Be Used to Discriminate Against the Elderly in Allocating Scarce Resources in the Context of COVID-19.Leniza de Castro-Hamoy & Leonardo D. de Castro - 2020 - Asian Bioethics Review 12 (3):331-340.
Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs.Baruch A. Brody & Udo Schuklenk - 1998 - Bioethics 12 (1):79-81.
The Toughest Triage — Allocating Ventilators in a Pandemic.Robert D. Truog, Christine Mitchell & George Q. Daley - 2020 - New England Journal of Medicine.
Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues.Udo Schüklenk & Carlton Hogan - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):400.
Analytics
Added to PP index
2020-08-26
Total views
9 ( #898,483 of 2,420,542 )
Recent downloads (6 months)
8 ( #87,806 of 2,420,542 )
2020-08-26
Total views
9 ( #898,483 of 2,420,542 )
Recent downloads (6 months)
8 ( #87,806 of 2,420,542 )
How can I increase my downloads?
Downloads
